171 - STI Management in Latin America and the Caribbean: Emerging Trends and Future Challenges

Friday, October 18, 2024

3:15 PM – 4:30 PM US PT

Location: 515 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Laila Woc-Colburn, MD (she/her/hers)

Associate Professor, Division of Infectious Disease
Emory University School of Medicine
Decatur, GA, United States
Carlos Franco-Paredes, MD, MPH

Faculty
Department of Medicine - Division of Infectious Diseases
Hospital Infantil de Mexico, Mexico and Instituto Conmemorativo de la Salud, Panama
Denver, CO, United States
Gustavo Lopardo, MD (he/him/his)

Department Infectious Diseases
FUNCEI
Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina

Faculty(s)

Alexis Holguín, MD (he/him/his)

President
Peruvian Society of Infectious and Tropical Diseases
Lima, Lima, Peru
Robert Paulino-Ramírez, MSc, MPH, DTM&H (he/him/his)

Principal Investigator
Universidad Iberoamericana (UNIBE), Dominican Republic
Valdilea Veloso, PhD (she/her/hers)

Researcher
Oswaldo Cruz Foundation, Brazil

Disclosure(s):

Laila Woc-Colburn, MD: No financial relationships to disclose

Carlos Franco-Paredes, MD, MPH: No financial relationships to disclose

Gustavo D. Lopardo, MD: Gilead Sciences: Advisor/Consultant (Ongoing); MSD argentina: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer, Inc.: Advisor/Consultant (Ongoing); ViiV Healthcare/GSK: Advisor/Consultant (Ongoing)

Alexis Holguín, MD: No financial relationships to disclose

Robert Paulino-Ramírez, MSc, MPH, DTM&H: No financial relationships to disclose

Valdilea Goncalves Veloso, PhD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the challenges in sti management in latin america;
describe emerging sti in the caribbean;
determine the challenges in the prevention and treatment of hiv in latam.

Presentations:

3:15 PM – 3:40 PM US PT

The Challenges in STI management in Latin America
Speaker: Alexis Holguín, MD (he/him/his) – Peruvian Society of Infectious and Tropical Diseases
3:40 PM – 4:05 PM US PT

PrEP and Treatment of HIV in LATAM
Speaker: Valdilea Goncalves Veloso, PhD (she/her/hers) – Oswaldo Cruz Foundation
4:05 PM – 4:30 PM US PT

Emerging STIs in The Caribbean
Speaker: Robert Paulino-Ramírez, MSc, MPH, DTM&H (he/him/his) – Universidad Iberoamericana (UNIBE)